Say NO to ROS: Their Roles in Embryonic Heart Development and Pathogenesis of Congenital Heart Defects in Maternal Diabetes
Congenital heart defects (CHDs) are the most prevalent and serious birth defect, occurring in 1% of all live births. Pregestational maternal diabetes is a known risk factor for the development of CHDs, elevating the risk in the child by more than four-fold. As the prevalence of diabetes rapidly rise...
Main Authors: | Anish Engineer, Tana Saiyin, Elizabeth R. Greco, Qingping Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/8/10/436 |
Similar Items
-
Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
by: Michael Demosthenous, et al.
Published: (2011-04-01) -
Pregestational Diabetes and Congenital Heart Defects
by: Catarina Maduro, et al.
Published: (2023-01-01) -
Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability
by: Anna Janaszak-Jasiecka, et al.
Published: (2021-07-01) -
Treatment With Tetrahydrobiopterin Improves White Matter Maturation in a Mouse Model for Prenatal Hypoxia in Congenital Heart Disease
by: Jennifer Romanowicz, et al.
Published: (2019-08-01) -
Tetrahydrobiopterin enhances myocardial blood flow in healthy volunteers: a double-blind placebo controlled study
by: G Schoedon, et al.
Published: (2001-02-01)